Mulmit

X4 Pharmaceuticals, IncX4 Pharmaceuticals, Inc

XFOR Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-3135,113,000-86,883,000-79,199,000-1.87
2024-12-312,557,000-36,401,000-37,450,000-5.59
2023-12-310-107,522,000-101,167,000-17.07
2022-12-310-87,569,000-93,867,000-1.52
2021-12-310-85,107,000-88,696,000-3.99

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-08-12Volpone JohnPresident24,576
2026-08-12Craig Adam RExecutive Chairman47,436
2026-07-01Gold Kelly110,000
2026-06-30KIRSKE DAVIDChief Financial Officer8,543
2026-05-12KIRSKE DAVIDChief Financial Officer16,961
2026-01-01Bridger Gary110,000
2026-01-01de Craecker Francoise110,000
2026-01-01WYZGA MICHAEL S110,000
2026-01-01Stewart Murray110,000
2025-10-29Volpone JohnPresident2,329,154
2025-10-29Craig Adam RExecutive Chairman2,329,154
2025-10-29KIRSKE DAVIDChief Financial Officer1,552,769

8-K events

FiledItems
2026-09-09Other events · Financial statements and exhibits
2026-09-08Other events · Financial statements and exhibits
2026-07-01Officer or director change · Regulation FD disclosure · Financial statements and exhibits
2026-05-13Officer or director change · Submission of matters to a vote · Financial statements and exhibits
2026-05-12Officer or director change · Submission of matters to a vote
2025-11-05Results of operations · Financial statements and exhibits
2025-10-27Entry into a material agreement · Financial statements and exhibits
2025-09-17Costs associated with exit or disposal activities · Officer or director change · Regulation FD disclosure · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size

SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.